Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | PNMT | P11086 | 2/20 | 0.54 |
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15345384 | 0.86 | PNMT (0.64) | CYP2A6CYP1A2PNMTDPP4LOXL2 | |
| SCHEMBL5052533 | 0.85 | LOXL2 (0.56) | CYP2A6CYP1A2PNMTDPP4LOXL2 | |
| SCHEMBL29463712 | 0.85 | LOXL2 (0.56) | CYP2A6CYP1A2PNMTDPP4LOXL2 | |
| Hydrochloric Acid SCHEMBL5691546 | 0.83 | LOXL2 (0.54) | CYP2A6PNMTDPP4LOXL2TAAR1 | |
| SCHEMBL1254359 | 0.83 | TAAR1 (0.57) | CYP2A6CYP1A2GPR84TAAR1 | |
| SCHEMBL7915217 | 0.79 | CYP2A6 (0.62) | CYP2A6CYP1A2PNMTKMT2AATM | |
| SCHEMBL5372145 | 0.79 | CYP2A6 (0.62) | CYP2A6CYP1A2KMT2AATMGPR84 | |
| SCHEMBL10409318 | 0.77 | CYP2A6 (0.59) | CYP2A6CYP1A2PNMTKMT2AATM | |
| SCHEMBL14444102 | 0.77 | CYP1A2 (0.59) | CYP2A6CYP1A2KMT2AATMGPR84 | |
| SCHEMBL6417657 | 0.77 | CYP2A6 (0.59) | CYP2A6CYP1A2PNMTKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2657214-B1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | MITSUBISHI GAS CHEMICAL CO (JP) | 2017-02-15 | — | — | EP | disclosed |
| US-8993774-B2 | Process for production of aromatic alcohol or heterocyclic aromatic alcohol | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20130303775-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-11-14 | — | — | US | disclosed |
| EP-2657214-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | Mitsubishi Gas Chemical Company, Inc. (JP) | 2013-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303775-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | ADH1C, ADH1A, ADH5 | CYP2A6 278/4885CYP1A2 98/4885PNMT 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.